Narsico, Rosemarie .
HRN: 11-32-58 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/15/2022
AMPICILLIN 1GM (VIAL)
07/15/2022
07/21/2022
IV
2g
Q6
PROM
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes